Gene · 5209
Papers3,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neuronal immunoproteasome and PFKFB3-forced glycolysis: key players in multiple sclerosis. | Signal Transduct Target Ther | 2025 | 40877259 | PubTator, text mining | PubMed |
| Joint Metabolomics and Transcriptomics Reveal Rewired Glycerophospholipid and Arginine Metabolism as Components of BRCA1-Induced Metabolic Reprogramming in Breast Cancer Cells. | Metabolites | 2025 | 40863152 | PubTator, text mining | PubMed |
| SP1-Mediated Glycolytic Reprogramming Promotes Tumorigenesis and Progression in Pancreatic Cancer. | Adv Sci (Weinh) | 2025 | 40832790 | PubTator, text mining | PubMed |
| The ATF4-glutamine axis: a central node in cancer metabolism, stress adaptation, and therapeutic targeting. | Cell Death Discov | 2025 | 40830338 | PubTator, text mining | PubMed |
| Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinoma. | Discov Oncol | 2025 | 40824331 | PubTator, text mining | PubMed |
| CD31 regulates metabolic switch in Treg migration attenuates rheumatoid arthritis. | Clin Transl Med | 2025 | 40817604 | PubTator, text mining | PubMed |
| Targeting tumor vascular endothelial cells for hepatocellular carcinoma treatment. | World J Gastroenterol | 2025 | 40809931 | PubTator, text mining | PubMed |
| Nintedanib Induces Mesenchymal-to-Epithelial Transition and Reduces Subretinal Fibrosis Through Metabolic Reprogramming. | Int J Mol Sci | 2025 | 40806264 | PubTator, text mining | PubMed |
| Stemness-hypoxia genes PPARGC1A, PFKFB3, and SLC2A5 are associated with prognosis and tumor immune microenvironment in hepatocellular carcinoma. | Transl Cancer Res | 2025 | 40792144 | PubTator, text mining | PubMed |
| Combined Analysis of Transcriptome and Mendelian Randomization Reveals AKT1 and PPARG as Biomarkers Related to Glucose Metabolism in Sepsis. | J Inflamm Res | 2025 | 40756416 | PubTator, text mining | PubMed |
| Metabolomics-guided analysis combined with network pharmacology and molecular simulations reveals the mechanism of JHT in treating septic intestinal dysfunction. | J Ethnopharmacol | 2025 | 40754029 | PubTator, text mining | PubMed |
| Deciphering enemy tactics - the narrow path to an optimal anti-cancer strategy targeting the Warburg effect. | Pharmacol Rep | 2025 | 40750753 | PubTator, text mining | PubMed |
| Research Progress on Glycolysis in the Pathogenesis of Asthma. | J Asthma Allergy | 2025 | 40746369 | PubTator, text mining | PubMed |
| PFKFB3 activates CAD to enhance de novo pyrimidine synthesis for cell growth. | Cell Rep | 2025 | 40742808 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. | MedComm (2020) | 2025 | 40740483 | PubTator, text mining | PubMed |
| Identification of breast cancer subtypes and drug response prediction through forward and reverse translation. | NPJ Precis Oncol | 2025 | 40739444 | PubTator, text mining | PubMed |
| Transient APC/C inactivation by mTOR boosts glycolysis during cell cycle entry. | Nature | 2025 | 40739344 | PubTator, text mining | PubMed |
| Hemodynamic homeostasis disequilibrium in critical illness. | Front Physiol | 2025 | 40735670 | PubTator, text mining | PubMed |
| Clinical application prospects of traditional Chinese medicine as adjuvant therapy for metabolic reprogramming in colorectal cancer. | Front Immunol | 2025 | 40735327 | PubTator, text mining | PubMed |
| Epigenomic diagnosis and prognosis of Acute Myeloid Leukemia. | Nat Commun | 2025 | 40730747 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5209/papers?page=10